Latest Mount Sinai Stories
The Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute today announced an affiliation agreement to collaborate on educational programs, research, and development of new diagnostic tools and treatments that promote human health. New York, NY and Troy, NY (PRWEB) May 22, 2013 The Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute today announced an affiliation agreement to collaborate on educational programs, research, and development of...
Drug associated with rapid antidepressant effect in largest clinical trial to date Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the Icahn School of Medicine at Mount Sinai. The antidepressant benefits of ketamine were seen within 24 hours, whereas traditional antidepressants can take days or weeks to demonstrate a...
Degenerative changes to the area of the spinal disc that absorbs most of shock felt with compression, known as the nucleus pulposus, has been demonstrated and reversed in a diabetic mouse model, according to a new study led by researchers at the Icahn School of Medicine at Mount Sinai. New York, NY (PRWEB) May 17, 2013 Degenerative changes to the area of the spinal disc that absorbs most of the shock felt with compression, known as the nucleus pulposus, has been demonstrated and reversed...
The Icahn School of Medicine at Mount Sinai has signed an agreement with bene pharmaChem GmbH to collaborate to conduct clinical studies of pentosan polysulfate (PPS) in patients with mucopolysaccharidoses (MPS). New York, NY (PRWEB) May 15, 2013 The Icahn School of Medicine at Mount Sinai has signed an agreement with bene pharmaChem GmbH to collaborate to conduct clinical studies of pentosan polysulfate (PPS) in patients with mucopolysaccharidoses (MPS). The company, based in Germany, is...
Using high-throughput sequencing, an international research team including Mount Sinai discovers causes of severe congenital heart disease New York, NY (PRWEB) May 12, 2013 Mutations in eight genes have been linked to severe forms of congenital heart disease (CHD), according to a study involving investigators at the Icahn School of Medicine at Mount Sinai. The study used an advanced technique known as high-throughput sequencing that enables scientists to obtain the sequence of all...
Mount Sinai’s International Center for Health Outcomes and Innovation Research (InCHOIR) is the data-coordinating center for the trial. New York, nY (PRWEB) May 10, 2013 Today the National Institute of Neurological Disorders and Stroke (NINDS) announced that “A Randomized Trial of Unruptured Brain Arteriovenous Malformations” (ARUBA) has stopped enrolling patients because of higher than expected event rates in the interventional therapy arm. The International Center for Health...
Nobel Prize-Winning Pyschologist Daniel Kahneman, PhD, Delivers Keynote Address and Receives Honorary Degree New York, NY (PRWEB) May 10, 2013 Two Nobel Prize winners and some of the nation’s leading health care philanthropists were honored at the Icahn School of Medicine at Mount Sinai’s 44rd commencement ceremony at Avery Fisher Hall at Lincoln Center. A total of 307 degrees were granted to medical students and students in the Graduate School of Biomedical Sciences, including 142...
‘Cureatr’ App Developed by Mount Sinai Hospital Resident Dr. Joseph Mayer New York (PRWEB) May 09, 2013 The Mount Sinai Medical Center has adopted an enterprise-grade mobile care-coordination mobile app called Cureatr, which was designed by a resident at the Mount Sinai Hospital, Joseph Mayer, MD. Mount Sinai has signed a multi-year contract to roll out the app to Mount Sinai clinicians. “Mount Sinai is the first major academic medical center to adopt Cureatr,” said Dr. Bruce J....
Mount Sinai Researcher Estimates that Lead Exposure Could Cause Mental Retardation in 6 in 1,000 Children Living Near the Sites New York, NY (PRWEB) May 07, 2013 Children living near toxic waste sites in lower and middle income countries such as India, Philippines and Indonesia may experience higher blood lead levels, resulting in a loss of IQ points and a higher incidence of mental retardation, according to a study presented today by Kevin Chatham-Stephens, MD, Pediatric Environmental...
Toxic waste sites with elevated levels of lead and chromium cause a high number of “healthy years of life lost” in individuals living near 373 sites located in India, Philippines and Indonesia, according to a study by a Mount Sinai researcher published online today in Environmental Health Perspectives. New York, NY (PRWEB) May 06, 2013 Toxic waste sites with elevated levels of lead and chromium cause a high number of “healthy years of life lost” in individuals living near 373...
